HDFC Pharma and Healthcare Fund vs PGIM INDIA HEALTHCARE FUND

HDFC vs PGIM· Portfolio Overlap Analysis

44.2%High Overlap
11 common stocksRank #17227 / 20,000

Investor takeaway: At 44.2% overlap, a significant part of these portfolios is identical. Despite coming from different AMCs, the stock picks still converge heavily. Make sure both funds actually serve different jobs in your allocation.

Common Holdings (11)

StockWt% in HDFC Pharma and HealthcareWt% in PGIM INDIA HEALTHCAREOverlap
Sun Pharmaceutical Industries Ltd.
Pharmaceuticals & Biotechnology
9.81%11.69%9.81%
Divis Laboratories Ltd.
Pharmaceuticals & Biotechnology
8.38%10.34%8.38%
Max Healthcare Institute Limited
Healthcare Services
6.36%5.81%5.81%
Aster DM Healthcare Limited
Healthcare Services
5.42%7.07%5.42%
Krishna Institute Of Medical Sciences Limited
Healthcare Services
3.61%4.35%3.61%
Torrent Pharmaceuticals Ltd.
Pharmaceuticals & Biotechnology
2.34%3.17%2.34%
Sai Life Sciences Limited
Pharmaceuticals & Biotechnology
2.09%2.98%2.09%
Anthem Biosciences Limited
Pharmaceuticals & Biotechnology
4.46%2.08%2.08%
Global Health Limited
Healthcare Services
1.84%1.95%1.84%
Dr. Lal Path Labs Ltd
Healthcare Services
1.63%2.83%1.63%
Rubicon Research Limited
Pharmaceuticals & Biotechnology
1.22%5.29%1.22%

Unique to HDFC Pharma and Healthcare

  • Glenmark Pharmaceuticals Ltd.6.62%
  • Lupin Ltd.6.44%
  • Alkem Laboratories Ltd.6.21%
  • Ipca Laboratories Ltd.4.80%
  • Fortis Healthcare Limited4.02%

Unique to PGIM INDIA HEALTHCARE

  • JB Chemicals & Pharmaceuticals Ltd.6.39%
  • Dr. Reddy's Laboratories Ltd.6.09%
  • Mankind Pharma Ltd.5.01%
  • Ajanta Pharma Ltd.4.94%

Sector Overlap Breakdown

Pharmaceuticals & Biotechnology
25.9% (6)
Healthcare Services
18.3% (5)

More comparisons for HDFC Pharma and Healthcare

More comparisons for PGIM INDIA HEALTHCARE

Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.